Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Five Prime Therapeutics, Inc.
Scientific Title
A Phase 1a/1b Study of FPA150, an Anti-B7-H4 Antibody, in Patients With Advanced Solid Tumors